Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

Authors

Keywords

Journal

Volume 13, Issue 9, Pages 879-886

Publisher

Elsevier BV

Online

2012-08-13

DOI

10.1016/s1470-2045(12)70324-8

Explore over 38,000 international journals covering a vast array of academic fields.

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started